Skip to main content

Advertisement

Table 1 Characteristics of the HCV genotype 1 and 2 infected patients with PEG-IFNα-RBV therapy

From: Association of MRC-1 and IL-28Bwith the treatment outcome of hepatitis C: a case control study

  HCV genotype 1 (HCV-1) HCV genotype 2 (HCV-2)
  All SVR (+) SVR (−) Pvalue All SVR (+) SVR (−) Pvalue
Number of patients 265 163 102 - 195 178 17 -
Sex (male/female) 129/136 84/79 45/57 0.2 88/107 81/97 7/10 0.7
Mean age ± SD 52.17 ± 10.27 50.69 ± 10.60 54.52 ± 9.29 0.002a 51.62 ± 10.89 51.15 ± 11.16 56.47 ± 5.86 0.05a
BMI (mean ± SD) 24.6 ± 3.1 24.2 ± 2.9 25.2 ± 3.3 0.03a 24.5 ± 3.5 24.5 ± 3.6 24.5 ± 2.7 0.9a
Viral load (×10 6 ) 12.1 ± 16.4 11.0 ± 16.5 13.9 ± 16.2 0.001a 11.0 ± 19.0 10.3 ± 17.8 18.4 ± 27.9 0.3a
  1. SVR, sustained virological response; BMI, body mass index.
  2. aMann–Whitney U test.